Medical management of children after liver transplantation

Current Opinion in Organ Transplantation

Volumn 19, Issue 5, 2014, Pages 474-479

  Miloh, Tamir ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Children; Liver transplantation; Medical management; Pediatric

Indexed keywords

CIDOFOVIR; CYCLOPHOSPHAMIDE; FOSCARNET; GANCICLOVIR; PREDNISONE; RITUXIMAB; TACROLIMUS; VALGANCICLOVIR;

ATOPY; AUTOIMMUNE HEPATITIS; CHILD CARE; CHRONIC HEPATITIS; COGNITIVE DEFECT; CYTOMEGALOVIRUS; DIABETES MELLITUS; EOSINOPHILIC GASTROINTESTINAL DISORDER; EPSTEIN BARR VIRUS; FOLLOW UP; GRAFT SURVIVAL; HEMATOLOGIC DISEASE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LIVER TRANSPLANTATION; MALIGNANT NEOPLASTIC DISEASE; MOUTH HYGIENE; NEPHROTOXICITY; NEUROLOGICAL COMPLICATION; POSTOPERATIVE COMPLICATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; SURGICAL INFECTION; VIRUS LOAD; ADVERSE EFFECTS; ALLOGRAFT; CHILD; EPSTEIN-BARR VIRUS INFECTIONS;

ALLOGRAFTS; CHILD; EPSTEIN-BARR VIRUS INFECTIONS; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; QUALITY OF LIFE; RECURRENCE;

EID: 84925715713     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000121     Document Type: Review

References (38)

1. Shepherd RW, Turmelle Y, Nadler M, et al. Risk factors for rejection and infection in pediatric liver transplantation. Am J Transplant 2008;8:396-403.
2. Tran L, Hebert D, et al. Invasive pneumococcal disease in pediatric organ transplant recipients: a high-risk population. Pediatr Transplant 2005;9:183-186.
3. Rook M, Rand E. Predictors of long-term outcome after liver transplant. Curr Opin Organ Transplant 2011;16:499-504.
4. Bedel AN, Hemmelgarn TS, et al. Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: comparison of prophylactic oral ganciclovir and oral valganciclovir. Liver Transpl 2012;18:347-354.
5. Asberg A, Bjerre A, et al. New algorithm for valganciclovir dosing in pediatric solid organ transplant recipients. Pediatr Transplant 2014;18:103-111. This study describes the different algorithms for oral valcyte dosing in children.
6. McDiarmid SV, Jordan S, et al. Prevention and preemptive therapy of posttransplant lymphoproliferative disease in pediatric liver recipients. Transplantation 1998;66:1604-1611.
7. Kerkar N, Morotti RA, et al. The changing face of posttransplant lymphoproliferative disease in the era of molecular EBV monitoring. Pediatr Transplant 2010;14:504-511.
8. Narkewicz MR, Green M, et al. Decreasing incidence of symptomatic Epstein-Barr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients: report of the studies of pediatric liver transplantation experience. Liver Transpl 2013;19:730-740. This SPLIT database analysis revealed that with frequent monitoring of EBV PCR and immunosuppression reduction, the incidence of symptomatic EBV and PTLD decreased in pediatric liver transplantation recipients. Younger recipients and those with multiple rejections remained at higher risk.
9. Tran TT, Gonzalez IA, et al. Lower respiratory tract viral infections in pediatric abdominal organ transplant recipients: a single hospital inpatient cohort study. Pediatr Transplant 2013;17:461-465. This retrospective study evaluated the epidemiology of children hospitalized with respiratory illnesses who are solid-organ recipients.
10. Gomez-Lobo V, Whyte T, et al. Immunogenicity of a prophylactic quadrivalent human papilloma virus L1 virus-like particle vaccine in male and female adolescent transplant recipients. Pediatr Transplant 2014;18:310-315. This study revealed that transplant adolescents developed 100% seroconversion to all four HPV serotypes with HPV vaccine with a nonsignificant increased incidence of acute rejection (AR) among kidney transplant vaccine recipients and not in liver transplant recipients.
11. Gavalda J, Cabral E, et al. Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients. Pediatr Transplant 2013;17:403-406. This study assessed the immunogenicity and safety of a vaccine against H1N1 in a prospective cohort of transplanted pediatric patients.
12. Squires RH, Ng V, et al. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American association for the study of liver diseases, American society of transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology 2014;60:362-398. This guideline by the AASLD, AST, and NASPGHAn offers recommendations for the evaluation of children for liver transplantation with emphasis on the different specific indication for liver transplantation in children.
13. McLin VA, Anand R, et al. Blood pressure elevation in long-term survivors of pediatric liver transplantation. Am J Transplant 2012;12:183-190.
14. Campbell K, Ng V, et al. Glomerular filtration rate following pediatric liver transplantation - the SPLIT experience. Am J Transplant 2010;10:2673-2682.
15. Kivela JM, Raisanen-Sokolowski A, et al. Long-term renal function in children after liver transplantation. Transplantation 2011;91:115-120.
16. Basso MS, Subramaniam P, et al. Sirolimus as renal and immunological rescue agent in pediatric liver transplant recipients. Pediatr Transplant 2011;15:722-727.
17. Kelly DA, Bucuvalas JC, et al. Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013;19:798-825. This article summarizes the key aspects of routine monitoring and medical management of children after liver transplantation, with consensus recommendations of the AASLD and AST.
18. Kuo HT, Lau C, Sampaio MS, Bunnapradist S. Pretransplant risk factors for new-onset diabetes mellitus after transplant in pediatric liver transplant recipients. Liver Transpl 2010;16:1249-1256.
19. Greig F, Rapaport R, et al. Characteristics of diabetes after pediatric liver transplant. Pediatr Transplant 2013;17:27-33. This article discusses the incidence, risk factors, and prognosis of diabetes after liver transplantation in children.
20. Rothbaum Perito E, Lau A, et al. Posttransplant metabolic syndrome in children and adolescents after liver transplantation: a systematic review. Liver Transpl 2012;18:1009-1028.
21. Kosola S, Lampela H, et al. Metabolic syndrome after pediatric liver transplantation. Liver Transpl 2014; doi: 10.1002/lt.23931. [Epub ahead of print] This national cross-sectional study of all children who underwent liver transplantation between 1987 and 2007 revealed that after a median postliver transplantation follow-up time of 12 years, half of all patients had no components of the metabolic syndrome. The prevalence of overweight and obesity was 20%, hypertension was 24%, high triglycerides9%, low HDL in 23%, impaired fasting glucose in 14%, and metabolic syndrome in 9%.
22. Ghosh PS, Hupertz V, et al. Neurological complications following pediatric liver transplant. J Pediatr Gastroenterol Nutr 2012;54:540-546.
23. Tryc AB, Pflugrad H, et al. New-onset cognitive dysfunction impairs the quality of life in patients after liver transplantation. Liver Transpl 2014;20:807-814. This study sheds light on the unrecognized new-onset cognitive dysfunction after liver transplantation in children.
24. Sorensen LG, Neighbors K, et al. Longitudinal study of cognitive and academic outcomes after pediatric liver transplantation. J Pediatr 2014;165:65-72; e62. This study showed that more young liver transplantation recipients than expected are at increased risk for lasting cognitive and academic deficits. Pretransplant markers of nutritional status and operative complications predicted intellectual outcome.
25. Liem RI, Anand R, et al. Risk factors for chronic anemia in pediatric orthotopic liver transplantation: analysis of data from the SPLIT registry. Pediatr Transplant 2012;16:137-143.
26. Miloh T, Arnon R, et al. Autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura in pediatric solid organ transplant recipients, report of five cases and review of the literature. Pediatr Transplant 2011;15:870-878.
27. Shroff P, Mehta RS, et al. Presentation of atopic disease in a large cohort of pediatric liver transplant recipients. Pediatr Transplant 2012;16:379-384.
28. Wisniewski J, Lieberman J, et al. De novo food sensitization and eosinophilic gastrointestinal disease in children postliver transplantation. Clin Transplant 2012;26:E365-E371.
29. De Bruyne R, Dullaers M, et al. Posttransplant food allergy in children is associated with liver and not with renal transplantation: a monocentric comparative study. Eur J Pediatr 2013;172:1069-1075. This study reports the increased prevalence and associated factors with food allergy in children after liver transplantation.
30. Ferrazzano GF, Sangianantoni G, et al. Oral health status in liver transplant Italian children. Eur J Paediatr Dent 2013;14:323-327. This study elaborates on the high prevalence of caries and gingival diseases in liver transplant children.
31. Vivas AP, Bomfin LE, Costa WI Jr, et al. Oral granulomatosis-like lesions in liver transplanted pediatric patients. Oral Dis 2014;20:e97-e102. This study described specific oral mucosal lesions in liver-transplanted children.
32. Evans HM, Kelly DA, et al. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006;43:1109-1117.
33. Venturi C, Sempoux C, et al. Dynamics of allograft fibrosis in pediatric liver transplantation. Am J Transplant 2014;14:1648-1656. This study of 54 pediatric liver transplantation recipients revealed that progressive fibrosis was common and eluded to risk factors associated with graft fibrosis developing at specific area of the liver parenchyma.
34. Pinto J, Matos H, et al. Comparison of acoustic radiation force impulse/serum noninvasive markers for fibrosis prediction in liver transplant. J Pediatr Gastroenterol Nutr 2014;58:382-386. This article showed that ARFI may serve as a potential method for assessing significant fibrosis in pediatric patients with liver transplant, particularly in combination with AST/ALT ratio index.
35. Goldschmidt I, Stieghorst H, et al. The use of transient elastography and noninvasive serum markers of fibrosis in pediatric liver transplant recipients. Pediatr Transplant 2013;17:525-534. This study has shown that transient elastography correlated with the histological degree of fibrosis in liver-transplanted children.
36. Hubscher S. What does the long-term liver allograft look like for the pediatric recipient? Liver Transpl 2009;15:S19-S24.
37. Miloh T, Anand R, et al. Pediatric liver transplantation for primary sclerosing cholangitis. Liver Transpl 2011;17:925-933.
38. Chai PF, Lee WS, et al. Childhood autoimmune liver disease: indications and outcome of liver transplantation. J Pediatr Gastroenterol Nutr 2010;50:295-302.